Two- versus 24-hour infusion of cisplatin: pharmacokinetic considerations.
暂无分享,去创建一个
C. Anderson | R. Morris | P. Gill | J. Denham | R. Abbott | C. Olweny | I. Stafford | P. Reece | C. Anderson | S. Freeman
暂无分享,去创建一个
C. Anderson | R. Morris | P. Gill | J. Denham | R. Abbott | C. Olweny | I. Stafford | P. Reece | C. Anderson | S. Freeman